FDA NDC Directory · JSON-LD · Markdown

DABIGATRAN ETEXILATE

NDC 59651-975 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA208039
Dosage form / routeCAPSULE · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (150 mg/1)
Marketing started20250514
Package count2

External sources

Source: openFDA. Public-domain (CC0).